Josh Leisring
joshleisring.bsky.social
Josh Leisring
@joshleisring.bsky.social
Nephrologist / Hypertension Specialist in Columbus, Ohio
#Nephsky
He / him
Reposted by Josh Leisring
Our @ukkidney.org guidelines here in BMC Nephrology. 💯% agree that in-unit BP should ONLY be used for determining safety of individual HD sessions and NOT long-term CV risk modification. But changing practice will be a long haul.

link.springer.com/epdf/10.1186...
Management of blood pressure in adults, children and young people on dialysis: UK kidney association clinical practice guideline
link.springer.com
September 30, 2025 at 12:03 PM
At our center we do the initial screen without altering the existing meds. Don’t wanna miss the opportunity. Patients with the most overt PA have suppressed renin even on RAASi+thiazide. If results aren’t conclusive and suspicion still there can then washout or try empiric MRA. #NephJC
September 18, 2025 at 3:55 AM
Agree, screening seems like the most effective avenue to improve treatment rates on a broad scale.

Also, screening and making the diagnosis of PA in an individual patient allows tailored treatment including follow-up on plasma renin to help guide dose titration to get full benefit of MRA

#NephJC
September 18, 2025 at 3:30 AM
This is excellent! Multiple nice learning points all in one well-written case report.
August 21, 2025 at 6:07 PM